Worldwide Cancer Diagnostics Market will retain 8.1% CAGR to cross $156 Billion By 2024
SELLBYVILLE, Del., March 14, 2018 /PRNewswire-iReach/ -- The Industry growth report " Cancer Diagnostics Market Size By Application (Tumor Biomarkers Tests, Imaging, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization), By Cancer Type (Bladder Cancer, Breast Cancer, Colon and Rectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver-Lung Cancer, Melanoma, Non-Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer), By End-use (Hospitals , Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Russia, Japan, China, India, Australia, Mexico, Brazil, Argentina, South Africa, UAE, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024" by Global Market Insights, Inc. says Cancer Diagnostics Market share is expected to cross $156 Billion By 2024.
Increasing prevalence of cancer across the globe will be major driving factor for cancer diagnostics market. World Health Organization reported that cancer accounted for 8.8 million deaths in 2015 and was second leading cause of mortality. Unhealthy eating habits and changing lifestyle are further expected to boost prevalence in near future rendering significant positive impact on demand for better cancer diagnostic methods.
Increasing government initiatives to spread awareness pertaining to benefits of early diagnosis will boost cancer diagnostics market growth over the forecast timeframe. Awareness and accessibility of cancer diagnostic products is lower in developing and underdeveloped regions. Private as well as government organizations are conducting awareness campaigns to educate people regarding the importance of early diagnosis. Such activities will influence industrial growth. For instance, Roche in partnership with China Cancer Rehabilitation Society (CCRS) conducted 'Run for Her' campaign to raise awareness about mammography.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2406
Recent technological advancements enabling quick and accurate diagnosis will propel cancer diagnostics market growth. Patients are receiving treatment specifically tailored with accordance to their genetic makeup with the help of diagnosis based of next generation sequencing and liquid biopsy. Advent of such technologies in near future will support industry growth.
However, prohibitive cost of diagnosis is hampering adoption rates in countries with low income levels. Risk of radiations exposure will further impede market growth over the forecast period.
Imaging application segment held largest revenue share in 2016 and the trend is expected to continue over the forecast timeframe owing to wide range of applicability of imaging devices to detect majority of cancer types. Advent of technologically advanced devices such as computed tomography and positron emission tomography devices will positively impact market growth. These devices provide high quality imaging at lower radiation dose. The side effects associated with usage of some conventional imaging devices due to radiation exposure will hinder segment growth to some extent.
Browse key industry insights spread across 250 pages with 84 market data tables & 10 figures & charts from the report, "Cancer Diagnostics Market" in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/cancer-diagnostics-market
The liver-lung cancer application segment accounted for majority of market share in 2016. The segment growth is largely supported by increasing prevalence due to changing dietary habits such as increasing alcohol consumption and smoking.
U.S. dominated cancer diagnostics market in 2016, due to high research and development activities focused at developing better diagnostic methods. Presence of leading medical technology and biotechnology firms coupled with high adoption rates of technologically superior diagnostic methods will drive the U.S. cancer diagnostics market growth over the forecast timeframe.
China cancer diagnostic market should witness robust growth due to presence of large patient pool and increasing disposable income. Growing awareness pertaining to benefits of early diagnosis will propel market growth. However, being a price sensitive market, inflated cost of some advanced diagnostic tests may limit regional growth to some extent.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2406
Some of the key industry players operating in global cancer diagnostics market are Sienna Cancer Diagnostics, F. Hoffmann-La Roche, Becton, Dickinson and Company, C.R. Bard, Qiagen, Abbott Laboratories, Hoffmann-La Roche, Thermo Fisher Scientific, Siemens AG, Bio Rad Laboratories, GE Healthcare, Illumina, Koninklijke Philips, Toshiba Medical Systems Corporation, Agilent Technologies, and Hologic. Industry players are trying to garner higher market share through various organic as well as inorganic growth strategies. The companies in the industry are further trying to develop cost-effective and accurate diagnostics methods to get a competitive edge.
Browse Related Reports:
Global Vaccines Market Size 2017 – 2024
Global Vaccines Market share was valued over USD 32 billion in 2016 and is expected to witness more than 9% CAGR from 2017 to 2024. Rising prevalence of several infectious and non-infectious diseases globally coupled with increasing funding for vaccine development will drive the vaccines market trends.
https://www.gminsights.com/industry-analysis/vaccines-market
Cancer Gene Therapy Market Size 2016 – 2024
Cancer Gene Therapy Market share was USD 805.5 million in 2015, with 20.7% CAGR estimation from 2016 to 2024. Rapid technological advancements, increased adoption of emerging genomic technologies such as NGS and high density micro array are some of the factors that will drive global cancer gene therapy market over the forecast period.
https://www.gminsights.com/industry-analysis/lung-cancer-diagnostics-market
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: [email protected]
Web: https://www.gminsights.com
Blog: https://www.gminsights.com/blogs
Connect with us: Facebook | Google+ | LinkedIn | Twitter
Media Contact: Arun Hegde, Global Market Insights, Inc., +13028467766, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Global Market Insights, Inc.
iReach LastName, iReachCompany, 111-222-3333, [email protected]
Share this article